New England Capital Financial Advisors’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.19K Hold
161
﹤0.01% 359
2026
Q1
$966 Hold
161
﹤0.01% 377
2025
Q4
$1.15K Buy
161
+1
+0.6% +$8 ﹤0.01% 368
2025
Q3
$1.71K Hold
160
﹤0.01% 355
2025
Q2
$1.55K Hold
160
﹤0.01% 352
2025
Q1
$2.38K Buy
160
+3
+2% +$46 ﹤0.01% 305
2024
Q4
$2.34K Buy
157
+3
+2% +$49 ﹤0.01% 314
2024
Q3
$2.94K Buy
154
+2
+1% +$41 ﹤0.01% 296
2024
Q2
$3.14K Buy
152
+2
+1% +$40 ﹤0.01% 297
2024
Q1
$2.82K Buy
150
+2
+1% +$34 ﹤0.01% 295
2023
Q4
$2.13K Buy
148
+4
+3% +$54 ﹤0.01% 317
2023
Q3
$2.5K Buy
144
+2
+1% +$42 ﹤0.01% 303
2023
Q2
$2.95K Sell
142
-86
-38% -$1.87K ﹤0.01% 292
2023
Q1
$5.36K Buy
228
+3
+1% +$81 ﹤0.01% 288
2022
Q4
$7.06K Buy
+225
New +$5.75K 0.01% 273

Other funds holding OGN

New England Capital Financial Advisors's OGN Position: Q2 2026 in Review

New England Capital Financial Advisors held its Organon & Co (OGN) position steady in Q2 2026 at 161 shares worth $2.19K. The position accounts for ﹤0.01% of the portfolio, ranked #359.

New England Capital Financial Advisors first reported a position in OGN in Q4 2022 and has held it in 15 quarters since. The position peaked at $7.06K in Q4 2022. 172 funds tracked by Wall St. Rank hold OGN as of Q2 2026.

  • New England Capital Financial Advisors held 161 shares of Organon & Co worth $2.19K as of Q2 2026.
  • New England Capital Financial Advisors left its Organon & Co share count unchanged in Q2 2026.
  • Organon & Co made up ﹤0.01% of New England Capital Financial Advisors's portfolio in Q2 2026, its #359 holding.
  • New England Capital Financial Advisors first reported a position in Organon & Co in Q4 2022 and has held it in 15 quarters since.
  • New England Capital Financial Advisors's Organon & Co position peaked at $7.06K in Q4 2022.
  • 172 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.

Based on New England Capital Financial Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.